AIMS: Socioeconomic status (SES) is a powerful predictor of incident coronary disease and adverse cardiovascular outcomes. Understanding the impact of SES on heart failure (HF) development and subsequent outcomes may help to develop effective and equitable prevention, detection, and treatment strategies METHODS AND RESULTS: A systematic literature review of electronic databases including PubMed, EMBASE, CINAHL, and the Cochrane Library, restricted to human subjects, was carried out. The principal outcomes were incidence, prevalence, hospitalizations, mortality, and treatment of HF. Socioeconomic measures included education, occupation, employment relations, social class, income, housing characteristics, and composite and area level indicators. Additional studies were identified from bibliographies of relevant articles and reviews. Twenty-eight studies were identified. Lower SES was associated with increased incidence of HF, either in the community or presenting to hospital. The adjusted risk of developing HF was increased by ∼30-50% in most reports. Readmission rates following hospitalization were likewise greater in more deprived patients. Although fewer studies examined mortality, lower SES was associated with poorer survival. Evidence defining the equity of medical treatment of patients with HF was scarce and conflicting. CONCLUSIONS: Socioeconomic deprivation is a powerful independent predictor of HF development and adverse outcomes. However, the precise mechanisms accounting for this risk remain elusive. Heart failure represents the endpoint of numerous different pathophysiological processes and 'chains of events', each modifiable throughout the disease trajectories. The interaction between SES and HF is accordingly complex. Disentangling the many and varied life course processes is challenging. A better understanding of these issues may help attenuate the health inequalities so clearly evident among patients with HF.
AIMS: Socioeconomic status (SES) is a powerful predictor of incident coronary disease and adverse cardiovascular outcomes. Understanding the impact of SES on heart failure (HF) development and subsequent outcomes may help to develop effective and equitable prevention, detection, and treatment strategies METHODS AND RESULTS: A systematic literature review of electronic databases including PubMed, EMBASE, CINAHL, and the Cochrane Library, restricted to human subjects, was carried out. The principal outcomes were incidence, prevalence, hospitalizations, mortality, and treatment of HF. Socioeconomic measures included education, occupation, employment relations, social class, income, housing characteristics, and composite and area level indicators. Additional studies were identified from bibliographies of relevant articles and reviews. Twenty-eight studies were identified. Lower SES was associated with increased incidence of HF, either in the community or presenting to hospital. The adjusted risk of developing HF was increased by ∼30-50% in most reports. Readmission rates following hospitalization were likewise greater in more deprived patients. Although fewer studies examined mortality, lower SES was associated with poorer survival. Evidence defining the equity of medical treatment of patients with HF was scarce and conflicting. CONCLUSIONS: Socioeconomic deprivation is a powerful independent predictor of HF development and adverse outcomes. However, the precise mechanisms accounting for this risk remain elusive. Heart failure represents the endpoint of numerous different pathophysiological processes and 'chains of events', each modifiable throughout the disease trajectories. The interaction between SES and HF is accordingly complex. Disentangling the many and varied life course processes is challenging. A better understanding of these issues may help attenuate the health inequalities so clearly evident among patients with HF.
Authors: Anna Fretz; Andrea L C Schneider; John W McEvoy; Ron Hoogeveen; Christie M Ballantyne; Josef Coresh; Elizabeth Selvin Journal: Am J Epidemiol Date: 2016-02-08 Impact factor: 4.897
Authors: Yevgeniy Khariton; Adrian F Hernandez; Gregg C Fonarow; Puza P Sharma; Carol I Duffy; Laine Thomas; Xiaojuan Mi; Nancy M Albert; Javed Butler; Kevin McCague; Michael E Nassif; Fredonia B Williams; Adam DeVore; J Herbert Patterson; John A Spertus Journal: Circ Cardiovasc Qual Outcomes Date: 2018-04
Authors: Benjamin W Van Tassell; Nayef A Abouzaki; Claudia Oddi Erdle; Salvatore Carbone; Cory R Trankle; Ryan D Melchior; Jeremy S Turlington; Clinton J Thurber; Sanah Christopher; Dave L Dixon; Daniel T Fronk; Christopher S Thomas; Scott W Rose; Leo F Buckley; Charles A Dinarello; Giuseppe Biondi-Zoccai; Antonio Abbate Journal: J Cardiovasc Pharmacol Date: 2016-06 Impact factor: 3.105
Authors: Bosco Baron-Franco; Gary McLean; Frances S Mair; Veronique L Roger; Bruce Guthrie; Stewart W Mercer Journal: Br J Gen Pract Date: 2017-04-10 Impact factor: 5.386
Authors: David Alejandro González-Chica; Robert Adams; Eleonora Dal Grande; Jodie Avery; Phillipa Hay; Nigel Stocks Journal: Qual Life Res Date: 2017-02-11 Impact factor: 4.147
Authors: Gregory J Fermann; Phillip D Levy; Peter Pang; Javed Butler; S Imran Ayaz; Douglas Char; Patrick Dunn; Cathy A Jenkins; Christy Kampe; Yosef Khan; Vijaya A Kumar; JoAnn Lindenfeld; Dandan Liu; Karen Miller; W Frank Peacock; Samaa Rizk; Chad Robichaux; Russell L Rothman; Jon Schrock; Adam Singer; Sarah A Sterling; Alan B Storrow; Cheryl Walsh; John Wilburn; Sean P Collins Journal: Circ Heart Fail Date: 2017-02 Impact factor: 8.790
Authors: Kevin J Clerkin; Arthur Reshad Garan; Brian Wayda; Raymond C Givens; Melana Yuzefpolskaya; Shunichi Nakagawa; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Donna M Mancini; Paolo C Colombo; Veli K Topkara Journal: Circ Heart Fail Date: 2016-10 Impact factor: 8.790